Literature DB >> 26190838

Xenograft bioprosthetic heart valves: Past, present and future.

Rizwan A Manji1, Whayoung Lee2, David K C Cooper2.   

Abstract

The transplantation (implantation) of xenograft heart valves into humans has been carried out for >50 years. There has been considerable research into making this form of xenotransplantation successful, though it is not perfect yet. We review the understanding of the immune response to xenograft heart valves. Important steps in the history include understanding (i) the importance of glutaraldehyde in decreasing the immune response and (ii) the relationship between calcification (which is the main problem leading to xenograft failure) and the immune response. We subsequently discuss the importance of identifying xenoantigens that are important in leading to xenograft valve failure, and the potential of genetically-engineered pigs to allow the development of the 'ideal' heart valve for clinical valve replacement.
Copyright © 2015 IJS Publishing Group Limited. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Calcification; Gal; Genetically-modified; Glutaraldehyde; Heart valves; NeuGc; Pigs; Xenograft rejection

Mesh：

Year:  2015        PMID： 26190838     DOI： 10.1016/j.ijsu.2015.07.009

Source DB:  PubMed          Journal:  Int J Surg        ISSN： 1743-9159            Impact factor:   6.071


  36 in total

1.  Pericardial tissue for cardiovascular application: an in-vitro evaluation of established and advanced production processes.

Authors:  L Grefen; F König; M Grab; C Hagl; N Thierfelder
Journal:  J Mater Sci Mater Med       Date:  2018-11-03       Impact factor: 3.896

Review 2.  In Search of the Ideal Valve: Optimizing Genetic Modifications to Prevent Bioprosthetic Degeneration.

Authors:  Benjamin Smood; Hidetaka Hara; David C Cleveland; David K C Cooper
Journal:  Ann Thorac Surg       Date:  2019-03-02       Impact factor: 4.330

3.  Impact of T-cell-mediated immune response on xenogeneic heart valve transplantation: short-term success and mid-term failure.

Authors:  Anna C Biermann; Julia Marzi; Eva Brauchle; Maria Schneider; Angela Kornberger; Sherif Abdelaziz; Julian L Wichmann; Christophe T Arendt; Eike Nagel; Kelvin G M Brockbank; Martina Seifert; Katja Schenke-Layland; Ulrich A Stock
Journal:  Eur J Cardiothorac Surg       Date:  2018-04-01       Impact factor: 4.191

Review 4.  Small Diameter Xenogeneic Extracellular Matrix Scaffolds for Vascular Applications.

Authors:  Manuela Lopera Higuita; Leigh G Griffiths
Journal:  Tissue Eng Part B Rev       Date:  2019-11-27       Impact factor: 6.389

Review 5.  Next-generation tissue-engineered heart valves with repair, remodelling and regeneration capacity.

Authors:  Emanuela S Fioretta; Sarah E Motta; Valentina Lintas; Sandra Loerakker; Kevin K Parker; Frank P T Baaijens; Volkmar Falk; Simon P Hoerstrup; Maximilian Y Emmert
Journal:  Nat Rev Cardiol       Date:  2020-09-09       Impact factor: 32.419

6.  Immunoproteomic Identification of Noncarbohydrate Antigens Eliciting Graft-Specific Adaptive Immune Responses in Patients with Bovine Pericardial Bioprosthetic Heart Valves.

Authors:  Katherine V Gates; Qi Xing; Leigh G Griffiths
Journal:  Proteomics Clin Appl       Date:  2018-12-19       Impact factor: 3.494

7.  Characterization of immunogenic Neu5Gc in bioprosthetic heart valves.

Authors:  Eliran Moshe Reuven; Shani Leviatan Ben-Arye; Tal Marshanski; Michael E Breimer; Hai Yu; Imen Fellah-Hebia; Jean-Christian Roussel; Cristina Costa; Manuel Galiñanes; Rafael Mañez; Thierry Le Tourneau; Jean-Paul Soulillou; Emanuele Cozzi; Xi Chen; Vered Padler-Karavani
Journal:  Xenotransplantation       Date:  2016-09-09       Impact factor: 3.907

Review 8.  Skin xenotransplantation: Historical review and clinical potential.

Authors:  Takayuki Yamamoto; Hayato Iwase; Timothy W King; Hidetaka Hara; David K C Cooper
Journal:  Burns       Date:  2018-03-27       Impact factor: 2.744

9.  Development of a Novel Human Cell-Derived Tissue-Engineered Heart Valve for Transcatheter Aortic Valve Replacement: an In Vitro and In Vivo Feasibility Study.

Authors:  V Lintas; E S Fioretta; S E Motta; P E Dijkman; M Pensalfini; E Mazza; E Caliskan; H Rodriguez; M Lipiski; M Sauer; N Cesarovic; S P Hoerstrup; M Y Emmert
Journal:  J Cardiovasc Transl Res       Date:  2018-08-13       Impact factor: 4.132

10.  Perigraft reaction and incorporation of porcine and bovine pericardial patches.

Authors:  Georg Schlachtenberger; Fabian Doerr; Annamaria Brezina; Hruy Menghesha; Matthias B Heldwein; Gerardus Bennink; Michael D Menger; Mohammed Moussavian; Khosro Hekmat; Thorsten Wahlers
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-04-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.